Serum albumin level is associated with mycophenolic acid concentration in children with idiopathic nephrotic syndrome

被引:3
作者
Nishimura, Tatsuya [1 ,3 ]
Uemura, Osamu [2 ]
Hibino, Satoshi [1 ]
Tanaka, Kazuki [1 ]
Kitagata, Ryoichi [1 ]
Yuzawa, Sotaro [1 ]
Kasagi, Toshiki [1 ]
Fujita, Naoya [1 ]
机构
[1] Aichi Childrens Hlth & Med Ctr, Dept Nephrol, Obu, Aichi, Japan
[2] Ichinomiya Med Treatment & Habilitat Ctr, Ichinomiya, Aichi, Japan
[3] Chiba Childrens Hosp, Dept Nephrol, Chiba, Japan
关键词
Mycophenolate mofetil; Mycophenolic acid; Albumin; Hypoalbuminemia; Nephrotic syndrome; Children; GLOMERULAR-FILTRATION-RATE; PROTEIN-BINDING; MOFETIL; PHARMACOKINETICS; EXPOSURE; THERAPY;
D O I
10.1007/s00431-021-04294-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Mycophenolate mofetil is effective for the treatment of pediatric idiopathic nephrotic syndrome (INS). The dosage of mycophenolate mofetil is adjusted according to the serum concentration of mycophenolic acid (MPA). Kidney function or cyclosporine (CsA) concentrations affect serum MPA levels. However, few studies have focused on the association between serum concentrations of MPA and albumin. This retrospective observational study aimed to evaluate the relationship between the serum concentrations of MPA and albumin in INS children. Subjects were children with INS who underwent the therapeutic drug monitoring of CsA and MPA. We obtained the serum albumin (sAlb) concentration, estimated glomerular filtration rate (eGFR), age, and MPA and CsA areas under concentration-time curves from 0 to 12 h (AUC(0-12)). Multiple linear regression analysis and generalized estimating equations were performed to predict values for MPA AUC(0-)(12). We obtained information for 51 INS children with 261 MPA AUC(0-12) measurements. The standardized regression coefficients of sAlb, eGFR, CsA AUC(0-12), and age were 0.54, - 0.21, - 0.07, and 0.04, respectively. Furthermore, MPA AUC(0-12) levels positively correlated with sAlb concentrations (p < 0.001) and were inversely correlated with eGFR values (p = 0.005) but not with CsA AUC(0-12) (p = 0.24) and age (p = 0.65). Conclusion: Serum albumin concentration was strongly associated with total MPA concentration compared with kidney function or CsA values. Although patients with INS may have a low serum concentration of total MPA in the presence of low sAlb concentration, close attention should be paid to the interpretation of the low MPA values.
引用
收藏
页码:1159 / 1165
页数:7
相关论文
共 26 条
  • [1] Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia
    Atcheson, BA
    Taylor, PJ
    Kirkpatrick, CMJ
    Duffull, SB
    Mudge, DW
    Pillans, PI
    Johnson, DW
    Tett, SE
    [J]. THERAPEUTIC DRUG MONITORING, 2004, 26 (03) : 284 - 286
  • [2] Clinical pharmacokinetics of mycophenolate mofetil
    Bullingham, RES
    Nicholls, AJ
    Kanmm, BR
    [J]. CLINICAL PHARMACOKINETICS, 1998, 34 (06) : 429 - 455
  • [3] Evaluation of a new pretreatment reagent for use with the EMIT®2000 cyclosporine assay
    Butch, AW
    Fukuchi, AM
    [J]. CLINICAL BIOCHEMISTRY, 2003, 36 (04) : 313 - 316
  • [4] Therapeutic Drug Monitoring of Mycophenolic Acid
    Dasgupta, A.
    [J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 76, 2016, 76 : 165 - 184
  • [5] Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
    de Winter, Brenda C. M.
    van Gelder, Teun
    Sombogaard, Ferdi
    Shaw, Leslie M.
    van Hest, Reinier M.
    Mathot, Ron A. A.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2009, 36 (06) : 541 - 564
  • [6] Mycophenolate mofetil in pediatric renal transplantation
    Ettenger, R
    Sarwal, MM
    [J]. TRANSPLANTATION, 2005, 80 (02) : S201 - S210
  • [7] Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study
    Falcini, F.
    Capannini, S.
    Martini, G.
    La Torre, F.
    Vitale, A.
    Mangiantini, F.
    Nacci, F.
    Cerinic, M. M.
    Cimaz, R.
    Zulian, F.
    [J]. LUPUS, 2009, 18 (02) : 139 - 143
  • [8] A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome
    Fujinaga, Shuichiro
    Ohtomo, Yoshiyuki
    Umino, Daisuke
    Takemoto, Mayako
    Shimizu, Toshiaki
    Yamashiro, Yuichiro
    Kaneko, Kazunari
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (01) : 71 - 76
  • [9] Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome
    Gellermann, Jutta
    Ehrich, Jochen H. H.
    Querfeld, Uwe
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1970 - 1978
  • [10] GUGLER R, 1976, Clinical Pharmacokinetics, V1, P25, DOI 10.2165/00003088-197601010-00003